Financial Report

Consolidated income statement

1 January - 31 December

kEUR

Note

2022

2021

 

 

 

 

Revenue

3

280,978

282,126

Other operating income

3

2,486

4,091

Total income

 

283,464

286,217

 

 

 

 

Cost of sales

 

-228,987

-182,426

Gross profit

 

54,477

103,791

 

 

 

 

Marketing and sales expenses

3

-4,905

-3,864

Research expenses

3

-1,243

-1,407

General and administrative expenses

3

-35,722

-34,355

Total operating expenses

 

-41,870

-39,626

 

 

 

 

Operating result (EBIT)

 

12,607

64,165

 

 

 

 

Financial income

3

9

653

Financial expenses

3

-5,049

-4,970

Total financial result

 

-5,040

-4,317

 

 

 

 

Result before income taxes

 

7,567

59,848

 

 

 

 

Income tax charges

5

200

-12,590

Result for the year

 

7,767

47,258

 

 

 

 

Attributable to shareholders of PolyPeptide Group AG

 

7,767

47,258

 

 

 

 

Earnings per share in EUR, basic

7

0.24

1.47

Earnings per share in EUR, diluted

7

0.24

1.47